<ѻýҕl>Two-Stage Screening Strategy for Ovarian Cancer Continues to Show Progressѻýҕl> Large study shows stage shift, high specificity, increasing PPV over 21 years Jan 24, 2024
<ѻýҕl>Early Detection Is Key to Higher Cure Rates in Ovarian Cancerѻýҕl> "We are not aware of precancer stages for ovarian cancer" Dec 13, 2023
<ѻýҕl>Cancer Patient's Final Act: Destroying Medical Debtѻýҕl> Viral campaign will erase some $60 million in medical debt Nov 22, 2023
<ѻýҕl>Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancerѻýҕl> Alone or combined with a PD-1 inhibitor, ubamatamab showed promise in phase I trial Nov 09, 2023
<ѻýҕl>T-DXd Tied to Encouraging Survival in HER2-Expressing Gyn Cancersѻýҕl> More responses, longer OS in subset with the highest levels of HER2 expression Nov 07, 2023
<ѻýҕl>RAF/MEK and FAK Inhibitor Combo Effective in Low-Grade Serous Ovarian Cancerѻýҕl> Impressive overall response rate with avutometinib-defactinib in RAMP 201 trial Nov 05, 2023
<ѻýҕl>In BRCA Breast Cancer, Prophylactic Salpingo-Oophorectomy Tied to Better Survivalѻýҕl> PSO should be performed early, particularly for those with the BRCA1 variant, researchers say Oct 04, 2023
<ѻýҕl>Preoperative Algorithm Might Halve Unnecessary Oophorectomies in Childrenѻýҕl> Researchers point to potential for reduction in lifelong consequences Oct 03, 2023
<ѻýҕl>Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enoughѻýҕl> Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
<ѻýҕl>How the Chemotherapy Shortage Is Affecting Frontline Cliniciansѻýҕl> "How are we here in 2023 having some of these discussions?" bemoans gynecologic cancer expert Sep 08, 2023 video
<ѻýҕl>New Ovarian Cancer Drug Extends Survival in Resistant Diseaseѻýҕl> "Practice changing" findings for tough-to-treat patient population Jun 04, 2023
<ѻýҕl>Pricey Drug Combo Boosts PFS in First-Line Advanced Ovarian Cancerѻýҕl> Questions about anti-PD-L1 contribution, cost, and access to durvalumab, bevacizumab, olaparib Jun 03, 2023
<ѻýҕl>Many With Cancer Predisposition Diseases Unaware of Genetic Statusѻýҕl> Moreover, a significant proportion do not qualify for genetic screening under current guidelines Apr 19, 2023
<ѻýҕl>Risks Outweigh Benefits for BSO at Benign Hysterectomy in Younger Womenѻýҕl> It's less clear-cut for postmenopausal women, study authors say Apr 18, 2023
<ѻýҕl>VTE Risk in Recurrent Ovarian Cancer Increases With More Lines of Chemotherapyѻýҕl> Prospective study in heavily treated population is warranted, researcher says Mar 30, 2023
<ѻýҕl>Novel Strategies Show Winning Potential in Ovarian Cancerѻýҕl> High response rates in small studies of immuno-oncology combination, neoadjuvant olaparib Mar 28, 2023
<ѻýҕl>CDK4/6 Inhibition Active in Recurrent Low-Grade Serous Ovarian Cancerѻýҕl> Responses in a fourth of patients, clinical benefit in up to 90% Mar 26, 2023
<ѻýҕl>OS Benefit Eludes Second-Line Niraparib Maintenance in Ovarian Cancerѻýҕl> Significant PFS results demonstrated in NORA trial don't extend to overall survival Dec 17, 2022
<ѻýҕl>FDA OKs First Antibody-Drug Conjugate for Platinum-Resistant Ovarian Cancerѻýҕl> Mirvetuximab soravtansine produced responses in almost a third of patients in pivotal trial Nov 15, 2022
<ѻýҕl>Pandemic Led to Surgical Delays in Gynecologic Cancers, and Worse Outcomesѻýҕl> One in five patients experienced changes in their care plan Oct 04, 2022
<ѻýҕl>Rucaparib a Winner for PFS, But Not for OS, in Recurrent Ovarian Cancerѻýҕl> PARP inhibitor still has value as maintenance therapy, ARIEL3 investigator says Oct 01, 2022
<ѻýҕl>'Potential Detrimental Effect' With Fourth-Line Olaparib in Ovarian Cancerѻýҕl> Post-hoc data from SOLO3 show diverging results based on prior lines of therapy Sep 30, 2022
<ѻýҕl>Maintenance PARP Inhibition Boosts OS in Two Ovarian Cancer Trialsѻýҕl> Results from SOLO-1 and PAOLA-1 show "clinically meaningful" long-term results with olaparib Sep 09, 2022
<ѻýҕl>Does PARP Inhibitor Maintenance Induce Platinum Resistance in Ovarian Cancer?ѻýҕl> Shorter progression-free interval with platinum chemotherapy after olaparib maintenance Sep 01, 2022
<ѻýҕl>Nonselective Beta-Blockers May Improve Outcomes in Ovarian Cancerѻýҕl> Lower all-cause, cancer-specific mortality in women who received the drugs around time of surgery Aug 29, 2022
<ѻýҕl>Two Sides of Endosalpingiosis: Benign Growth or Harbinger of Cancer?ѻýҕl> Concurrent malignancy more than twice as common as compared with endometriosis, study showed Aug 06, 2022
<ѻýҕl>Prosthetic Mesh May Stand in the Way of Further Abdominal Operationsѻýҕl> Prior incisional hernia repair associated with complications with later abdominal surgery Aug 04, 2022
<ѻýҕl>Another Possible Use for Aspirin: Reducing Ovarian Cancer Riskѻýҕl> Potential benefit seen in women with and without established cancer risk factors Jul 27, 2022
<ѻýҕl>Drugmaker Pulls Third-Line PARP Inhibitor Approval in Ovarian Cancerѻýҕl> Decision on rucaparib follows negative OS signal and "discussions" with FDA Jun 17, 2022
<ѻýҕl>PARP Inhibitor Picks Up a Win in Frontline Maintenance for Ovarian Cancerѻýҕl> Median PFS more than doubled with rucaparib after response to platinum-based chemotherapy Jun 07, 2022
<ѻýҕl>IL-15 Agonist Impresses in Non-Muscle Invasive Bladder Cancerѻýҕl> High response rate, 99%-100% cancer-specific survival at 2 years Jun 04, 2022
<ѻýҕl>New Clue to Risk of Peritoneal Cancer After Prophylactic Salpingo-Oophorectomyѻýҕl> Women with BRCA variant and serous tubal intraepithelial carcinoma had a 34-fold greater risk Apr 05, 2022
<ѻýҕl>Intraperitoneal Carboplatin Boosts PFS in Ovarian Cancerѻýҕl> Should the gynecologic oncology community reconsider IP therapy? Mar 22, 2022
<ѻýҕl>Novel ADC Promising in Tough-to-Treat Ovarian Cancerѻýҕl> Ocular AEs an issue with mirvetuximab in folate receptor alpha-high platinum-resistant disease Mar 20, 2022
<ѻýҕl>Adjuvant Chemo Disappoints in Low-Grade Serous Ovarian Cancerѻýҕl> Study suggests no improvement in overall survival Mar 19, 2022
<ѻýҕl>Uterine Cancer Mortality Now Neck and Neck With Ovarian Cancerѻýҕl> Advances in ovarian cancer, stagnation in uterine cancer, and "alarming" racial disparity Feb 09, 2022
<ѻýҕl>A Better Option for Preserving Fertility in Gynecologic Cancer Patients?ѻýҕl> In vitro maturation can result in both embryos and oocyte vitrification, researcher says Oct 19, 2021
<ѻýҕl>Christiane Amanpour's Ovarian Cancer and the Importance of Early Detectionѻýҕl> Renowned reporter calls on women to advocate for themselves Oct 11, 2021
<ѻýҕl>Another Checkpoint Inhibitor Misses Mark in Ovarian Cancerѻýҕl> No OS or PFS benefit with nivolumab versus chemotherapy for platinum-resistant disease Sep 24, 2021
<ѻýҕl>Rechallenge With PARP Inhibitor Slows Relapsed Ovarian Cancerѻýҕl> Benefits platinum-sensitive disease irrespective of BRCA, homologous repair status, study showed Sep 17, 2021